US Stock MarketDetailed Quotes

CATX Perspective Therapeutics

Watchlist
  • 12.0900
  • +0.2800+2.37%
Close Nov 1 16:00 ET
  • 12.0900
  • 0.00000.00%
Post 16:20 ET
815.20MMarket Cap-7283P/E (TTM)

Perspective Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Perspective Therapeutics Q3 2024 Estimates Date

Currency：USDNov 12, 2024

Estimate YoY
Revenue
153.23K
-91.97%
EPS
-0.22
+46.14%
Analyst Rating
Strong Buy

Nov 2, 2024

Perspective Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 157.810K--
Nov 12, 20242024/Q3-- / 153.230K--
Aug 12, 20242024/Q2526.000K / 135.630K--
May 15, 20242024/Q1325.000K / 68.800K--
--2023/Q4-4.902M / 2.122M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 157.810K--
Nov 12, 20242024/Q3-- / 153.230K--
Aug 12, 20242024/Q2526.000K / 135.630K--
May 15, 20242024/Q1325.000K / 68.800K--
--2023/Q4-4.902M / 2.122M--

Unlock Free Earnings Estimates

Perspective Therapeutics Earnings Reports

  • Perspective Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 13 16:10 ET

  • Perspective Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 15 22:44 ET

  • Perspective Therapeutics | 10-K: FY2023 Annual Report

    Mar 28 08:39 ET

  • Perspective Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 14, 2023 16:59 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 2, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data